Nick Kostovic was born on December 06, 1950 in an area now known as region Dalmatia, currently Split Croatia. I graduated from Split Gymnasium in 1969 with an Associate of Arts Degree in Humanities and Science. I am Italian and US citizen. I have strong Italian ties through my father, Ivo Kostovic who mother was Italian. Through his father roots he has and Asian origins. He was born on the island of Drvenik-Veli when it was part of region Dalmatia, Italy called Zirona. My mother Bosiljka Rodic Kostovic, great great grand daughter of Djurdja Mandic, mother of NikolaTesla with Russian roots, was born in city Omis also originally from Dalmatia region, Italy. Dalmatia was part of Italy for many centuries and currently Dalmatia is located in Croatia Europe.

Cancer & Viruses

Dr Shyam Reddy is a Professor and Director, Cancer Biology Program, Department of OB/GYN, Morehouse School of Medicine, Georgia Cancer center for excellence, Grady Memorial Hospital, Atlanta, Ga. He carried out his Ph.D. work at the Center for Cellular and Molecular Biology, Hyderabad, India and at Max Planck Institute for Biophysical Chemistry, Gottingen, West Germany. His Ph.D. work was published as two papers (back to back) in the prestigious Nature journal for which he was awarded National Young Scientist award by the Prime minister of India. He obtained postdoctoral training in molecular biology at Yale University, CT. Dr Reddy discovered and cloned several cancer genes/oncogenes (close to 20 genes) and studied their functions. The most notable genes discovered by Dr Reddy include ERG-1, ERG-2, ERG-3 and human FLI-1genes. Drs Reddy and Rao named the gene as ERG. ERG is a transcriptional factor, endothelial permeability factor and also a stem cell factor and is involved in 50-80% of Prostate cancers, Ewing sarcoma and also leukemias (AML). Other notable ETS genes discovered and studied by Dr Reddy include human Fli-1, EWS-Fli-1, EWS-erg, TLS-ERG, EWS , TLS/FUS, ELK-1 and EWS-ATF-1. Dr Reddy and his group have also discovered novel post-translational mechanism mediated by BRCA2 in Breast Cancer cells that will have global effect on the Gene Expression, Protein turnover, Cell Death, Cancer and other Human diseases. Recently, Dr Reddy’s group decoded non-coding DNA and it’s non-coding RNA and discovered novel tumor suppressors which will revolutionize the landscape of biology, diagnosis and therapy

Molecular Oncology, Signaling pathways, Noncoding DNA and RNA, Therapeutic Strategies, Oncogenes, Fusion -oncogenes

Professor Mokbel is a Consultant Oncoplastic Breast Surgeon at the London Breast Institute of The Princess Grace Hospital, London; Honorary Consultant Breast Surgeon at St George's Hospital NHS Trust, London; Professor of Breast Cancer Surgery at the Brunel University, London, and president of breast cancer hope charity. Professor Mokbel was named in Tatler magazine's Best Doctors Guide as one of the featured 'Top Breast Surgeons' in 2006 and 2007 and in November 2010 he was named in the Times magazine's list of Britain's Top Doctors. He graduated (MB,BS) from the University of London in 1990. Kefah was awarded several prestigious prizes during his undergraduate medical training at The London Hospital Medical College. He qualified as a Fellow of the Royal College of Surgeons (FRCS, England) in 1994. He was granted the Master of Surgery degree in 2000 by The Imperial College of Science, Technology and Medicine for his research in the field of molecular biology of breast cancer. Following this specialist accreditation, he was appointed as a substantive Consultant Breast Surgeon to St. George’s Hospital, and an Honorary Senior Lecturer in Surgery. In 2002, he was appointed a Professor at The Brunel Institute of Cancer Genetics and Pharmacogenomics (Brunel University, London, UK) in recognition of his contribution to breast cancer research. In 2005, he was appointed as a Reader in Breast Surgery at St. George’s University of London.

Professor Mokbel's clinical interests in the field of breast surgery include the early detection of breast cancer, breast ductoscopy, minimally-invasive breast surgery, sentinel node biopsy, skin and nipple sparing mastectomy, breast reconstruction, aesthetic breast surgery, breast lipofilling, prevention of breast cancer, genetic predisposition, and the management of benign conditions. His main research interest lies in the field of molecular biology and the clinical management of breast cancer. His prolific research output includes over 350 published papers in medical literature with an H-index of 45 and i10-index of 151. He has also written 14 books in various disciplines including surgery, oncology, breast cancer, and postgraduate medical education and is a member of the editorial board of several international medical journals.

 Distncton in Ophthalmology in Final Professional Examinaton.  First Positon in Physics in F.Sc. from Federal Government College for Women, F-7/2, Islamabad.  First FCPS (Clinical Oncology) in Pakistan Atomic Energy Commissionand frst female FCPS in the subject all over Pakistan  Third FCPS in Clinical Oncology all over the country  Nominated Member of Faculty of Clinical Oncology by CPSP in October 2015  Designated Head Oncology and Radiology Departments NORI from 7th March 2016  Vice President Pakistan Society of Clinical Oncology  Member Faculty of Radiotherapy CPSP  Member Board of Studies for M.Sc Radiaton Medical Oncology PIEAS University  Member of Radiaton Safety Commitee of NORI  Member team for the preparaton and fnaliiaton of PC-1 for NORI  Member team for preparaton of specifcatons of equipment for Oncology and Radiology Depts NORI  Member Natonal Steering Commitee of Cancer Registry under Pakistan Health Research Council

 Delivered a short lecture on “The role of concomitant chemoradiotherapy in locally advanced squamous cell carcinomas of anal canal” in Natonal scientfc conference of Pakistan Medical Associaton Rawalpindi Islamabad Chapter from 21-03-2003 to 23-03-2003  Delivered a short lecture on “Diet and Cancer” in Pakistan Medical Associaton Rawalpindi Islamabad Chapter 359th Clinical Meetng held at NORI in May, 2005

Prof. Dr. Alireza Heidari, Ph.D., D.Sc. is a Full Professor and Academic Tenure of Chemistry at California South University (CSU), Irvine, California, USA. He has got his Ph.D. and D.Sc. degrees from California South University (CSU), Irvine, California, USA. Furthermore, he has double postdocs in Project Management, Oncology, Human Cancer Tissues and Synchrotron Radiation from Monash University, Melbourne, Victoria, Australia and also in Nanochemistry and Modern Molecular Electronic–Structure Computations Theory from California South University (CSU), Irvine, California, USA.

His research interests include Biophysical Chemistry, Biomolecular Spectroscopy, Quantum Chemistry, Nanochemistry, Modern Electronic Structure Computations, Theoretical Chemistry, Mathematical Chemistry, Computational Chemistry, Vibrational Spectroscopy, Molecular Modelling, Ab initio & Density Functional Methods, Molecular Structure, Biochemistry, Molecular Simulation, Pharmaceutical Chemistry, Medicinal Chemistry, Oncology, Synchrotron Radiation, Synchrocyclotron Radiation, LASER, Anti–Cancer Nano Drugs, Nano Drugs Delivery, ATR–FTIR Spectroscopy, Raman Spectroscopy, Intelligent Molecules, Molecular Dynamics, Biosensors, Biomarkers, Molecular Diagnostics, Numerical Chemistry, Nucleic Acids, DNA/RNA Monitoring, DNA/RNA Hypermethylation & Hypomethylation, Human Cancer Tissues, Human Cancer Cells, Tumors, Cancer Tissues, Cancer Cells, etc.

Dr. Monther AlAlwan is a scientist at the Stem Cell and Tissue Re-engineering Program (SCTRP), King Faisal Specialist Hospital and Research Centre, as well as an Associate professor at Alfaisal University, Riyadh Saudi Arabia. He holds M.Sc. and Ph.D. in Immunology from Dalhousie University (Halifax, Canada). Dr. AlAlwan conducted a 3-years postdoctoral fellowship studying signaling in immune cells at the University of Manitoba, Canada. During his graduate studies and postdoctoral fellowship, Dr. AlAlwan made substantial contribution in the immunology field, particularly his groundbreaking discovery that highlighted the significance of the dendritic cells in the immunological synapse. After joining the SCTRP in 2007, he shifted gear to study cancer, where he identified novel mechanisms that regulate cancer metastasis and chemoresistance.

Currently, he is actively involved in dissecting the molecular pathways that regulate the function of cancer stem cells and how this related to chemoresistance and metastasis. Dr. AlAlwan is an author in 25 peer-reviewed publications, has delivered several invited lectures and is a regular reviewer for various international journals.

In 1996, Dr Andrès received his MD degree in Internal Medicine, at the University of Strasbourg, France. He worked as an associated professor in the University Hospital of Strasbourg, France. In 1998 he worked as PhD in Molecular Biology in the Laboratory of Professor Hoffmann (2011, Nobel Prize of Medicine) in the field of cationic antimicrobial peptides and pathogens - host relations. In 2002, he was nominated Professor at the University of Strasbourg, France. He also was in the head of an Internal Medicine Department (of 62 beads) in the University hospital of Strasbourg, France. He was awarded the French Society of Haematology, price for research in the field of anaemia related to cobalamin or folate deficiencies in 2004. Achievements include development of research in: all type of anaemia, neutropenia and thrombocytopenia, particularly drug-induced neutropenia and agranulocytosis or thrombocytopenia; haematopoietic growth factors; and cobalamin deficiencies. He also conducts several studies on inflammatory or immune disorders. His recent works also include research and development on human sounds analysis, electronic stethoscope, e-auscultation, and e-medicine. In that function he was recruited as advisor to several pharmaceutical and telemedicine companies or start-up.

Immunity; Host-Pathogens Relation; Immune Cytopenias; Systemic Immune And Inflammatory Diseases; Chronic Pathologies, Telemedicine, Drug-Induced Side Effects, Vitamin Deficiency

I am a Lebanese Medical Oncologist currently working in Breast-Gynecological Oncology and Neuro-Oncology Departments at Erasme University Hospital, Brussels, Belgium. I am also engaged in the Clinical Trial Conduct Unit (CTCU) at Jules Bordet Institute in Brussels. I received my Diploma in Internal Medicine and Hematology-Oncology from Saint Georges Hospital University Medical Center- University of Balamand, Beirut, Lebanon in June 2014 and June 2017 respectively. This is my second year in Belgium. My first year was at Jules Bordet Institute where I had rotations and oncology consultations in the following fields: breast cancer, gynecological malignancies, melanoma, head and neck cancers, sarcoma and other rare tumors, genito-urinary, gastro-intestinal and thoracic malignancies. I also attended many academic activities at Jules Bordet Institute, as well as many debates and scientific meetings in Belgium, Europe and USA. I was able to publish many case reports, communications, editorial letters, review and opinion articles in many peer-reviewed journals, as well as many poster presentations, view the high level of exposure I had at Jules Bordet Institute. In September 2017, I got the chance to attend for the second time the meeting of the Society of Hematologic Oncology (SOHO) in collaboration with MD Anderson at Houston-Texas, where I was designed an ambassador for Belgium in the Society of Hematologic Oncology, and a member in the SOHO Ambassadorship program. Furthermore, I am an active editorial board member in many peer review journals and the editor-in-chief of the Acta Scientific Cancer Biology Journal (ASCB). I am also a reviewer in the Journal of Clinical Oncology in addition to other peer review, open access journals.

Gynecological Malignancies; Breast Cancer; Neuro-Oncology; Supportive care mainly women health/quality of life during/after anti-neoplastic treatments.

o Member of Amiri training team for teaching and training haematology staff, Amiri Hospital o Member of research team in Haematology Department o Chairman of Laboratory Utilization Committee

• Primer design • Reverse Transcription • qPCR, Cloning • Protein expression and purification • Western & Northern Blot • ELISA • Transfection • Cell based assays • Dissection • FACS • Blood collection • Blood coagulation analysis • Bone marrow staining • Blood smear preparation, staining, and differential • Research writing • Data analysis • Team work

Ahmed Gilani, MD, PhD is a pathologist at the Children’s hospital Colorado, University of Colorado, Aurora, CO. He holds a PhD from Graduate School of Arts and Science, Columbia University, NY. He is a diplomate of the American Board of Pathology with subspecialty qualifications in Neuropathology and Pediatric Pathology. He is an author or coauthor of various peer reviewed publication in the fields of pathology, neuroscience and public health and policy. He has presented his research at various national and international conferences and a member of several prestigious medical and scientific professional associations including: American Medical Association, College of American Pathologists, United States and Canadian Academy of Pathology, Society for Neuroscience and the Society for Biological Psychiatry.

Diagnostic neuropathology and pediatric pathology, central nervous system development and psychiatric disorders.

Dr. Hiu Yee KWAN is currently an Assistant Professor in the School of Chinese Medicine, Hong Kong Baptist University. She obtained her B.Sc. degree in The Hong Kong University and PhD degree in The Chinese University of Hong Kong before receiving her postdoctoral training at the University of California, Berkeley, U.S.A. She is interested in the study of obesity-associated cancers.

1) Obesity-associated Cancers 2) Obesity 3) Therapeutic phytochemicals

I was born in Mexico city, i work in oncogynecology , laparoscopic surgery, and endometrial cancer. I wrote 30 medical papers and 5 book´s chapters. 3 years ago i worked as director in a ambulatory medical unit with surgery, chemotherapy , haemodialysis, endoscopy. Actually i word in a third unit medical hospital.

My area of interest is oncology in gynecology.